14th Nov 2005 07:01
Allergy Therapeutics PLC14 November 2005 14 November 2005 Allergy Therapeutics plc CHANGE OF ADVISER AND BROKER Following completion of the acquisition of the UK Equity Capital Marketsdivision of Robert W Baird Limited by Bridgewell Securities Limited, AllergyTherapeutics plc is pleased to announce the appointment of Bridgewell SecuritiesLimited as Nominated Adviser and Broker with immediate effect. For further information please contact: Allergy Therapeutics 01903 844720Keith Carter, Chief Executive Bridgewell Securities Limited 020 7003 3000Shaun Dobson, Managing Director This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Allergy Thera.